Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Jenner

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
Frontiers in Immunology|April 28, 2023
CD90 is not constitutively expressed in functional innate lymphoid cellsJan-Hendrik Schroeder, Gordon Beattie, Jonathan W Lo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesRichard G Jenner, Michael J Townsend, Ian Jackson, et al.
Lancet (London, England)|April 19, 1986
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's diseaseF J Grandas Perez, P G Jenner, M Nomoto, et al.
The Journal of Biological Chemistry|October 13, 2010
Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid proteinLuciano Vozzolo, Belinda Loh, Paul J Gane, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.
Journal of Virology|February 24, 2012
Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elementsMichael J McClellan, Sarika Khasnis, C David Wood, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2010
An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's diseaseC A Jones, L C Johnston, M J Jackson, et al.
The Journal of Clinical Investigation|February 12, 2019
microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune toleranceNelomi Anandagoda, Joanna Cd Willis, Arnulf Hertweck, et al.
Nucleic Acids Research|May 21, 2015
Splicing of a non-coding antisense transcript controls LEF1 gene expressionManuel Beltran, Estel Aparicio-Prat, Rocco Mazzolini, et al.
Cell Reports|February 17, 2015
The Dnmt3L ADD Domain Controls Cytosine Methylation Establishment during SpermatogenesisGeorgios Vlachogiannis, Chad E Niederhuth, Salih Tuna, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Frontiers in Immunology|April 28, 2023
CD90 is not constitutively expressed in functional innate lymphoid cellsJan-Hendrik Schroeder, Gordon Beattie, Jonathan W Lo, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesRichard G Jenner, Michael J Townsend, Ian Jackson, et al.
Lancet (London, England)|April 19, 1986
(+)-4-Propyl-9-hydroxynaphthoxazine in Parkinson's diseaseF J Grandas Perez, P G Jenner, M Nomoto, et al.
The Journal of Biological Chemistry|October 13, 2010
Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid proteinLuciano Vozzolo, Belinda Loh, Paul J Gane, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1989
Antiparkinsonian activity of CY 208-243, a partial D-1 dopamine receptor agonist, in MPTP-treated marmosets and patients with Parkinson's diseaseJ A Temlett, N P Quinn, P G Jenner, et al.
Journal of Virology|February 24, 2012
Downregulation of integrin receptor-signaling genes by Epstein-Barr virus EBNA 3C via promoter-proximal and -distal binding elementsMichael J McClellan, Sarika Khasnis, C David Wood, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2010
An in vivo pharmacological evaluation of pardoprunox (SLV308)--a novel combined dopamine D(2)/D(3) receptor partial agonist and 5-HT(1A) receptor agonist with efficacy in experimental models of Parkinson's diseaseC A Jones, L C Johnston, M J Jackson, et al.
The Journal of Clinical Investigation|February 12, 2019
microRNA-142-mediated repression of phosphodiesterase 3B critically regulates peripheral immune toleranceNelomi Anandagoda, Joanna Cd Willis, Arnulf Hertweck, et al.
Nucleic Acids Research|May 21, 2015
Splicing of a non-coding antisense transcript controls LEF1 gene expressionManuel Beltran, Estel Aparicio-Prat, Rocco Mazzolini, et al.
Cell Reports|February 17, 2015
The Dnmt3L ADD Domain Controls Cytosine Methylation Establishment during SpermatogenesisGeorgios Vlachogiannis, Chad E Niederhuth, Salih Tuna, et al.
Pageof 10